On July 18, the official information disclosure system of the Stock Exchange of Hong Kong showed that Huajian Medical (01931.HK) issued an announcement announcing the official launch of the "IVDNewCo Exchange" ecological plan and launching the world's first RWA exchange focusing on the high-tech assets of the medical innovative drug NewCo. Exchange ecosystem and supporting issuance of IVDD stablecoin plan. Huajian Medical is actively promoting a landmark strategic move, which is to build a "NewCo + RWA + Web3" exchange ecosystem with high-tech assets of innovative medical drugs as the core. The ecosystem will be named "IVDNewCo Exchange" and will issue a proprietary stablecoin (IVDDollar "IVDD"). This strategy aims to subvert the development rules of the traditional pharmaceutical industry and improve the liquidity, financing efficiency and accessibility of global medical innovative drug assets by integrating Web3 technology (including RWA real-world asset tokenization, blockchain transactions and stablecoin mechanism). The following will explain in detail the strategic concept, progress, own advantages and future plans of this ecosystem.